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ABSTRACT:
Bckground: Diabetic neuropathy is the worst consequence of diabetes mellitus leading to nerve dysfunction that is
the cause of several complications such as pain, loss of sensitivity, damage to body systems, foot ulcers, morbidity and
amputations etc. The aim of the present work was to study the prevalence of risk factors and occurrence of diabetic
neuropathy in patients with diabetes, and how much diabetic neuropathy complications affect the life of diabetic
patients.
Methods: Study in the urban areas of Karachi was conducted based on survey (interview questionnaire), and
measurements/sample collection (blood pressure, physical activity, BMI, blood glucose and lipid profile) in male and
female healthy controls and patients with diabetes (age range for both groups: 35-75).
Results: Results demonstrated that the family history, aging, long duration of diabetes, tobacco addiction, heavy
alcohol consumption, uncontrolled glucose level, hypertension, dyslipidemia, and lack of physical activity were found
to be the major factors causing increase in neuropathic complications in patients with diabetes. However, controlling
the modifiable risk factors helped in improving the progression of diabetic neuropathy and general status of patients’
health.
Conclusions: it is recommended that awareness should be given to diabetic patients about their life style interventions
that may lead to better healthy life with fewer neuropathic complications. Conclusively, the patients could become able
to successfully prevent and delay the incidence of neuropathy by proper care, healthy diet, increasing level of physical
activity and controlling the risk factors.
Keywords: Diabetes mellitus, diabetic neuropathy, neuropathic risk factors, modifiable risk factors

INTRODUCTION: Diabetes mellitus is considered as a
metabolic disorder wherein hyperglycemia occurs due
to deficiency in production and secretion of insulin from
pancreas or inability of body cells to respond to insulin
secreted through pancreas, or both conditions
simultaneously.1,2 Basic and clinical research in
diabetes mellitus has provided profound information on
the pathophysiological constructs of diabetic
complications for long term outcome research.3 Oral
and intravenous glucose tolerance tests and related
other tests manifest the metabolic predictors for
impaired glucose tolerance in type 2 diabetes mellitus
(T2 DM) patients.4 Diabetes may cause damage to
body organs including kidneys, eyes, heart, blood
vessels, nerves etc. 5 Metabolic processes are altered
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due to hyperglycemia resulting in oxidative stress,
production of advanced glycation end products, polyol
pathway influx and activation of protein kinases and
hence, damage to nerves and ultimately microvascular
disease and neuropathy.6 Prevalence of T2DM
increases with increase in the prevalence of obesity
that necessitates to adopt weight centered approach
and consider the relevance of weight in the
management of T2DM patients.7 It has been suggested
that quite critical cases may require glucose range to
be maintained around 140-180mg/dL by continuous
infusion of insulin 1 . A recent review 8 describes the
antidiabetic drugs in the management of T2DM for
lowering the elevated blood level of glucose.
One of the adverse complications of diabetes is
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diabetic neuropathy9-11 that may cause multidirectional
disturbances affecting different regions of body, nerve
damage, disturbance in routine daily life activities and
work, mood disorders, lack of sleep and energy and
lack of social interaction leading to worst quality of life.
Peripheral neuropathy increases the likelihood of foot
complications like ulcers and amputation and Charcot
joints, whereas damage to the autonomic functions
including bladder problems, reproductive problems,
gastric problems including nausea, appetite loss,
diarrhea, constipation etc are the result of autonomic
neuropathy5 .Peripheral
neuropathy
is
mainly
responsible for morbidity and mortality in diabetic
patients, and patients with sensorimotor neuropathy
facing pain, numbness or tingling and loss of sensation,
whereas the autonomic neuropathy may be responsible
for cardiac autonomic neuropathy causing myocardial
infarction, malignant arrhythmia, spontaneous death,
gastro paresis, and sex related problems such as
sterility, erectile dysfunction and bladder problems 6 . It
has been reviewed recently. 9
Furthermore, autonomic neuropathy increases the risk
of mortality in diabetic patients through indirect
mechanisms like renal failure or by direct mechanisms
like cardiac failure or respiratory arrest 12 .
Morphological changes in peripheral diabetic
neuropathy are loss of myelination, proliferation of
Schwann cells, thickening of Schwann cell basement
membrane, damage and death of nerve root and axons
in autonomic diabetic neuropathy sympathetic ganglia
showing segmental demyelination and degeneration of
axons 12 . Other changes are large sized vacuoles in
sympathetic ganglion cells, swellings of dendrites and
degeneration of neurons, some irregularity in
esophageal nerves, reduction in density of myelinated
splanchnic nerve fibers, thickening, hyperargentophilia,
breaking and damaging of autonomic nerve fibers,
reduction in nerve cells, greatly reduced cholinesterase
activity in nerves of bladder wall, and marked reduction
in number of small myelinated or unmyelinated axons
in nerve biopsies in patients with diabetic peripheral or
autonomic neuropathy are the important findings 12 .
The most important risk factors of diabetic neuropathy
are hyperglycemia, age, duration of diabetes mellitus,
visceral obesity, height, hypertension, smoking,
hypoinsulinemia, and dyslipidemia 2,13 . Hypertension
and abnormalities of lipoprotein metabolism are often
found in people with diabetes5. Hypertension has
strong association with DSP (distal symmetric
polyneuropathy) in people with short term duration or
long term duration of insulin dependent diabetes
mellitus (IDDM). Blood pressure is significantly higher
in cases of diabetic neuropathy 14 More than 75% of
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adults with diabetes mellitus have blood pressure levels
≥130/80 mmHg and they use antihypertensive
medication 15 .
Hypertension is considered an important risk factor for
diabetic neuropathy. Hypertensives having low
Na+K+ATPase activity and having polyol disturbances
may lead to neurological disturbances, and those
having ischemia may cause diabetic neuropathy also
leading to renal disturbances 14. Hypertension may
reduce density of myelination of peripheral nerves that
shows that hypertension may cause peripheral diabetic
neuropathy or may exaggerate the complications of
peripheral diabetes neuropathy 14.
Hyperglycemia is the main initial cause of neuropathy,
retinopathy, nephropathy, and the patients are on high
risk of atherosclerotic disease, heart problems,
peripheral arterial disorders and cerebrovascular
disease 5. Hyperglycemia and poor glycemic control are
considered as the greatest risk factors for
complications associated with diabetes including nerve
damage leading to diabetic neuropathy 16 though it has
been suggested that recent data support the role for
components in metabolic syndrome and other risk
factors in the development of diabetic neuropathy that
indicates the possible novel targets beyond
hyperglycemia in therapeutics 10. It has been found
slightly higher in individual with IGT (impaired glucose
tolerance) and IFG (impaired fasting glucose) than in
individuals with NGT (normal glucose tolerance) 17. It
has been shown that high level of urinary albumin and
hyperglycemia may increase the mortality risk in
patients with non-insulin dependent diabetes mellitus
(NIDDM) 18. Dyslipidemia may contribute in the
development of diabetic neuropathy 19. It has been
proposed that occurrence of diabetic neuropathy
depends upon various risk factors including
dyslipidemia, obesity, smoking and hypertension 13. We
have done several studies on the role of cholesterol in
patients with diabetes mellitus 2,20-22. Dyslipidemia may
leads to cardiovascular disease that is considered as
the major cause of morbidity and mortality in diabetic
neuropathy13.Obesity is the risk factor and complication
in diabetes, hypertension and CVD (cardiovascular
disease). About 18 million patients die per year due to
CVD that relates to obesity that is considered as the
risk factor for microvascular complications of diabetes
such as diabetic neuropathy 23 . Defect in motor and
sensory nerve conduction velocity, tactile allodynia and
inability to sense alteration in temperature and
impaired glucose tolerance were observed in obese
mice fed with high fat diet (HFD) for inducing obesity,
although when hyperglycemia was excluded the mice
showed augmented sorbitol pathway activity in the
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including the specific criteria. Aims and objectives of
research were expressed to all study subjects. After
taking the consent of subjects, the detailed
questionnaire was filled out by them through interviews.
Socioeconomic status, basal body weight, family
history of disease, and basic inquiry about diabetes
were asked from patients. Presence of risk factors of
diabetic neuropathy and symptoms related to diabetic
neuropathy were marked by patients. Blood pressure
was recorded and estimation of glycemic and lipid
levels was done. The influence of diabetic neuropathy
on the quality of life of subjects in the present study
was enquired from subjects and assessed.
The level of physical activity of study subjects was
categorized into 3 classes- low, moderate and high.
This categorization is based on PAL (physical activity
level).
PAL was obtained by using the following equation:

peripheral nerve, as well as 4-hydroxynonenal adduct
nitrotyrosine and poly(ADP-ribose) accumulation and
12/15-lipoxygenase over expression in peripheral nerve
and dorsal root ganglion neurons 24.
Cigarette-smoking
associated
to
increased
complications of diabetic neuropathy 25 might be due to
any of the 4000 toxic compounds and since smoking
may cause narrowing and stiffness of arteries, reducing
the flow of blood in body extremities, delay in wound
healing due to ischemia, insulin resistance and
enhancing the risk of diabetic macrovascular and
microvascular
complications
causing
further
complications in diabetic nephropathy, retinopathy and
neuropathy 26 . Hence, cessation of smoking may also
be effective in glycemic control 2,20,26,27.
Diabetic neuropathy including acute and chronic forms
is the most common complication associated to
diabetes mellitus as manifested in the research work
carried out in the pathophysiological and management
aspects of diabetic neuropathy over the past decade9 .
Designing the fuzzy expert system has been found quite
helpful for specialists and general practitioners in
detecting and diagnosing the severity of diabetic
neuropathy for diagnosing the disease more quickly
and improving the quality of patients’ care 11. The non
modifiable risk factors of diabetic neuropathy (age,
height, duration of diabetes, gender, heredity
predisposition etc) have shown association with
diabetic neuropathy e.g. a strong relationship between
duration of diabetes, age and diabetic neuropathy; and
a considerable association of gender with neuropathy;
and male and tall diabetic patients of age more than 40
on risk of diabetic neuropathy16. Controlling the
modifiable risk factors has been found to be helpful in
improving the progression of diabetic neuropathy and
general status of patients’ health. Therefore,
awareness should be given to patients about their life
style interventions that may lead to better healthy life
with fewer neuropathic complications in patients with
diabetes mellitus.

PAL = TEE/24 hours
BMR/BEE
Where,
TEE =total energy expenditure, BMR=basal metabolic
rate, BEE=basal energy expenditure
Total energy expenditure (TEE) = BEE x AF
AF = activity factor
Basal energy expenditure (BEE) equation:
For males: 66+13.7(wt) +5.0(ht) -6.8(age)
For females: 655+9.6(wt) +1.8(ht)-4.7 (age)
Where, wt = basal body weight in kg, ht = body height
in cm, age = age in years
PHYSICAL/PHYSIOLOGICAL MEASUREMENTS:
Blood pressure: Sphygmomanometer was used to
measure the blood pressure. Before taking recordings
of BP the study subject was asked to relax and sit back
calmly with ease. After 5 minutes the deflated cuff was
wrapped around the bare upper arm and the valve on
the rubber bulb was closed. The stethoscope was
placed over the pulse, under the cuff. The cuff was then
pumped up by squeezing the bulb, and as the pressure
was released the korotkoff sounds were heard through
the ear pieces of the stethoscope. The blood pressure
(systolic/diastolic) was measured in terms of
millimeters of mercury mm Hg.
BMI: In order to determine whether the patient was
obese or not, the body mass index (BMI) was
calculated for every individual in the study. After
measuring the basal body weight in kilograms and
height in meters, BMI was calculated by using Metric
formula.

MATERIALS AND METHODS
Research design:
This study was conducted in urban areas of Karachi.
The prospective study was both survey and sample
based. The sample size of study is 300 out of which
150 are control subjects and 150 are the patients.
Healthy individuals were included in control group and
the diabetic patients who had 5 years duration from the
onset of diabetes were enrolled in patients group. The
age limit for both groups ranged between 35 to 75
years of age. There was no reservation on gender of
patient. The detailed questionnaire was designed by
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Diagnostic tests:

Fig 2

Blood glucose level: Blood glucose level of study
subjects was checked by using glucometer. First
enquired from the patients whether they were in fasting
state or random state, and instructed for fasting level
requirements with their consent. A new lancet and strip
was utilized for each subject. A cotton swab dipped in
alcohol was taken for cleaning the index finger of study
subjects before pricking. Subjects were instructed to
place the drop of blood on the strip on the place of
mark, and then to wait till reading appears on the
screen. Readings were noted and recorded.

Figure 3 shows that diabetes and other complications
associated to diabetic neuropathy had strong relation
with inheritance. The patients had higher family history
of disease. 82.67% of patients and 32.67 % of
controls had family history of diabetes. 60.67% patents
and 25.33% controls reported family history of
hypertension. Family history of kidney diseases was
reported by 26% of patients and 6% of controls. It was
found that 48% patients and 4.67% of controls had
family history of CVD.

Lipid profile:

Figure 4 shows that the study subjects had a variety of
chronic diseases. Zero % patients and 0% controls had
diabetes type 1. Diabetes type 2 was reported by 100%
of patients and 0% of controls, 62% patients and
0.67% of controls had dyslipidemia. Hypertension was
observed in 72% of patients and 0% of controls. The
prevalence of CVD was 0% in controls and 10% in
patients. The lung disorders were 2.67% in patients
and 0% in controls. Zero % of controls and 5.33% of
patients specifically had kidney disorders.

Fig 3

The lipid profile (levels of LDL, HDL and VLDL) was done
by kit method. Blood of patients was taken and
centrifuged. Plasma was stored in refrigerator at
required temperature. Later the aliquots of the sample
were used for the assessment of lipid profile.
Statistical analysis:
Statistical analysis and comparisons were carried out
by assessing the range, percentage and mean values.
Chi-square test was applied to check the significance
levels of the relevant data. The p value <0.05 was
considered significant, p value<0.01 highly significant
and p value<0.001 very highly significant.

Fig 4
It was observed that the level of physical activity was
poor in patients as compared to controls. 66.67%
patients and 38% of controls had low level of physical
activity. 27.33% patients and 42.67% controls had
moderate level of physical activity. High level of physical
activity was observed in 19.33% of controls and only
6% of patients (Figure 5).

RESULTS AND DISCUSSION
Results obtained in the present study (n: 300; 50 %
healthy control subjects and 50% diabetic patients)
were obtained from two groups, the control group
(38.67 % male subjects, 61.33 % female subjects) and
the patients group (45.33% males, 54.67 females)
(Figure 1).

Fig 5
The unawareness and carelessness were observed high
in population. Majority of patients were unaware of the
importance of checking blood sugar level. 24.67%
patients reported that they check their blood sugar
once a week. Twice in a week was reported by 8.67%
patients. 6.67% patients told that they check their
sugar level thrice a week. 3.33% patients reported that
they check their sugar level 4 to 5 times a week. 2.67%
were those checking six times a week. 8.67 % majority
of those who were on insulin reported that they check
their blood sugar level daily. 42% patients are those
who reported that they do not check their blood sugar
in a week (Figure 6).

Fig 1
Influence of age in the present study was analyzed for
the subjects in the range of 35 to 75 years age. The
range of age group was further divided into four groups
mentioned below.
It is shown in Figure 2 that the range values of age in
four age groups were:
Age group I: (36-45 years; 16.67% patients of total
patients, 47.33% controls of total controls)
Age group II: (46-55 years; 42.67% patients of total
patients, 23.33% controls of total controls)
Age group III:(56-65 years; 28.67% patients of total
patients, 19.33% controls of total controls)
Age group IV:(66-75 years; 12.00% patients of total
patients, 10.00% controls of total controls)
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Fig 6
Figure 7 shows that the prevalence of all risk factors
such as tobacco addiction, heavy alcohol consumption,
hypertension, hyperglycemia, obesity, kidney disorders
was significantly higher (p<0.05) in patients group as
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compare to controls group. The prevalence of tobacco
addiction was observed 0% in control and 32% in
patients group. Alcohol addiction was obtained in very
few percent of population because of religious terms
and conditions but in patient group 3.33 % of alcohol
addiction was observed while in control it was observed
in 0% of study subjects. The prevalence of renal
disease was observed 0% in control group and 10% in
patient group. Hyperglycemia was found markedly
higher in patient group which was 80% whereas in
control group its prevalence was 0%. Hypertension was
the 2nd highest risk factor which was observed to be
76.67% in patient group and 0% in controls.
Dyslipidemia was found in higher percentage in patient
group about 60% and 0% in control group. Obesity was
observed 60% in patient group which is quite high than
in control group which had 3.33% prevalence of
obesity.

management aspects 9-11 are helpful in interpreting
the findings. In accordance to present study smoking
and alcohol addiction, hypertension, hyperglycemia,
kidney disease, dyslipidemia and obesity are the
important risk factors of diabetic neuropathy. It was
revealed 12 that the significant correlation was present
between prevalence of diabetic neuropathy with
smoking (p<0.001), dyslipidemia (p<0.001). The
significant correlation existed between prevalence of
symptoms of diabetic neuropathy in patient who had
tobacco addiction. The prevalence of tobacco addiction
is significantly higher in patients in comparison of
control (p<0.05). In present study the prevalence of
smoking is 32% patients and 0% in controls. The
prevalence of dyslipidemia was extensively studied in
one study in patients with diabetic neuropathy 28 . In
present study the dyslipidemia is significantly higher in
patients (p<0.05) than control group. Dyslipidemia
was observed 0.67% in controls and 60% in patients. It
has been concluded that the hyperglycemia is
responsible for neural and vascular damage. In another
study, 38% diabetic patients showed hyperglycemia 29
. In present study 80% patients had hyperglycemia. The
prevalence of hyperglycemia is significantly higher in
patients than control (p<0.05), therefore according to
present study the hyperglycemia is the major risk factor
for complications of diabetic neuropathy. It was found
14 that long duration of diabetes, uncontrolled blood
pressure, hypertension, hyperglycemia and smoking
were all independent risk factors of the likelihood of
distal symmetric polyneuropathy (all p < 0.0001,
except for smoking for which p = 0.03). The
hypertension was noted to have relationship with
vascular disease in diabetes 30 . The blood pressure was
higher in patients than control group. Similar results for
the role of blood pressure in patients with diabetes
mellitus were obtained in another study2 . In our current
study, it is also evident that hypertension that was
76.67% in patient group and 0% in control group ; and
there was significant (p<0.05) relationship between
hypertension and diabetic neuropathy. Electrolyte
changes in patients with diabetes mellitus obtained in
our previous work 2,21 is quite interesting and provides
evidence of the influence of blood pressure in diabetes
mellitus. Neuropathy may occur in at least 65% of
patients who are about to begin dialysis for chronic
renal failure 31 . In the present study the prevalence of
kidney disease is significantly higher (p<0.05) in
patients as compared to control group. Prevalence of
neuropathy in patients with renal disease was
evaluated that provided better idea 32 . Alcohol
consumption may be responsible for absence of leg
reflexes and autonomic dysfunction but there was no

Fig 7
Table 1 shows the prevalence of symptoms in study
subjects. It was observed that the prevalence of the
observed symptoms were significantly higher (p<0.05)
in patient group as compared to control group.
TABLE 1
Figure 8 shows the level of severity of diabetic
neuropathy in patient group. 13.33% of patients were
reported little severe level of diabetic neuropathy,
30.67% were reported moderate level of severity in
diabetic neuropathy and 56% of patients were claimed
high level of severity.
Fig 8
Diabetic neuropathy was observed to become worsen
with time so large number of patients claimed that the
complications and symptoms related to diabetic
neuropathy were going to exaggerate with time (Figure
9).
Fig 9
The 20% subjects reported that diabetic neuropathy put
little impact on their life, 32% reported that diabetic
neuropathy added moderate level of complications on
their life and 48% reported that diabetic neuropathy
harshly put high level of bad impact on their life (Figure
10).
Fig 10
In the present study, it was observed that diabetic
neuropathy has direct relationship with duration of
diabetes since 94% patients showed long duration of
diabetes at least for more than 5 years. Detailed
studies about the insights for the diagnostic and
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significantly higher scores (impaired QOL) in 5/6 in that
assessment of NHP domains than the diabetic patients
who had no symptoms of neuropathy (p < 0.01) or
than who were non-diabetic (p < 0.001) controls. The
diabetic patients with neuropathy had emotional
distress, lack of energy, pain, physical mobility and
sleep disturbance. In the current study little impact of
neuropathy was reported by 13.33% of patients,
moderate impact of neuropathy was observed in
30.67% of patients while high impact of neuropathy on
quality of life was reported as 56% of patients. Our
previous work on endothelial dysfunction, cytokines and
diabetes mellitus 2,22,27,39 specially leptin
2,20,21,39 and ischemia and adipokines 2,20
emphasizes for studying the involvement of cytokines
and ischemia in relation to various risk factors in
patients with diabetes mellitus and diabetic patients
with diabetic neuropathy.
Hence, to clarify the
pathobiological aspects in diabetic neuropathy requires
further studies considering the important and recent
investigations 1-4,7-11,40 to understand the
pathophysiological changes occurring in diabetic/
diabetic neuropathic patients with various risk factors.

significant correlation between of alcohol consumption
and neuropathy 13 . In our study the prevalence of
alcohol consumption was 3.33% in patient group and
0% in control group. It was found that the obese
patients showed significantly decreased compound
muscle action potential amplitude of tibial and peroneal
nerves and decreased sensory action potential
amplitude of all nerves33 . Most of the sensory
thresholds were altered in obese patients. Insulin
serum levels were significantly increased in obese
patients. It was also observed that high level of
triglycerides and BMI higher than 30 were risk factors
for progression of complication related to diabetic
neuropathy 34 . These factors enhanced the risk of
neuropathy (p<0.05). It was observed that obesity and
triglycerides were related to loss of small unmyelinated
axons. These findings indicated that obesity and
hyperglycemia significantly increase risk for peripheral
neuropathy, independent of glucose control. In our
study it was observed that the prevalence of obesity
was significantly higher in patient with diabetic
neuropathy than to control group (p>0.05).The
prevalence of obesity is 60% in patient group and
3.33% in control group. The exercise intervention had
been associated with improved neuropathic symptoms,
nerve function, and cutaneous innervation in patients
with peripheral diabetic neuropathy 35 . They observed
the significant reduction in pain (− 18.1 ± 35.5 mm
on a 100 mm scale, p = .05), neuropathic symptoms
(− 1.24 ± 1.8 on mnsi, p = .01), and increased intra
epidermal nerve fiber branching (+ 0.11 ± 0.15
branch nodes/fiber, p = .008) in patients who did
aerobics and other strenuous exercise. There was
positive association between physical activity and
health-related quality of life 36 . In present study, there
was highly significant low level of physical activity
observed in patient group in comparison with control
group (p>0.0001). Our previous studies also point out
the involvement of physical activity and diet in diabetes
mellitus 2,21 .It was investigated that diabetic
neuropathy put significant impact on the quality of life
and diabetic neuropathy was considered as financial
burden 37 . In our study the higher number of patients
complained for symptoms of peripheral neuropathy
such as muscle weakness especially in legs 88%, bone
and joint pain 79%, numbness and tingling 76% and
sharp pain and cramps 72% (Table 1). The quality of life
(QOL) was found to be badly affected by diabetic
neuropathy 38 that was assessed by the QOL using the
Nottingham health profile (NHP). The NHP was based
on six domains assessing energy, sleep, pain, physical
mobility, emotional reactions and social isolation. The
diabetic patients who had neuropathic symptoms had
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CONCLUSIONS
The prevalence of diabetic mellitus type 2 has
increased much in our population and complications
associated with diabetes are also increasing day by day.
One of the major complications of diabetes is diabetic
neuropathy. The prevalence of diabetic neuropathy is
quite high in our population and it is is increasing
gradually because of unawareness of risk factors that
contribute in adding complications in diabetic patients.
Therefore, the patients could become able to
successfully prevent and delay the incidence of
neuropathy by proper care, healthy diet, increasing
level of physical activity and controlling the risk factors.
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